Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Casper Webers, Augusta Ortolan, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 130-141
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 19-34
Open Access | Times Cited: 506
Axial spondyloarthritis
Victoria Navarro‐Compán, Alexandre Sepriano, Dafne Capelusnik, et al.
The Lancet (2025) Vol. 405, Iss. 10473, pp. 159-172
Closed Access | Times Cited: 1
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
Augusta Ortolan, Casper Webers, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 142-152
Open Access | Times Cited: 58
Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review
Chrysoula G. Gialouri, Μαρία Παππά, Gerasimos Evangelatos, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 7, pp. 103357-103357
Closed Access | Times Cited: 25
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs
Fares Al Mohamad, Valeria Ríos Rodríguez, Hildrun Haibel, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e004009-e004009
Open Access | Times Cited: 7
Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies
Giacomo Cozzi, Laura Scagnellato, Mariagrazia Lorenzin, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 8, pp. 503-518
Closed Access | Times Cited: 20
Incidence rates of tuberculosis and inflammatory bowel disease in patients with ankylosing spondylitis treated with biologics in Korea
Oh Chan Kwon, Hye Sun Lee, Juyeon Yang, et al.
Lara D. Veeken (2025)
Closed Access
Personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs for treating ankylosing spondylitis: a clinical and economic evaluation with predictive modeling
Hai-Binh Bui, Thi Thu Phuong Nguyen, Trang Vu, et al.
Research Square (Research Square) (2025)
Closed Access
Barriers and facilitators to treat-to-target in axial spondyloarthritis in clinical practice: a mixed methods study
M. Smits, Casper Webers, Marieke van Dooren, et al.
Rheumatology International (2025) Vol. 45, Iss. 2
Open Access
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)
Colm Mac Eochagáin, Nina Rosa Neuendorff, Karolina Gente, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 2, pp. e90-e102
Closed Access
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study
Fanny Alcira Reyes Neira, Bárbara Bayeh, Karina Rossi Bonfiglioli, et al.
Exploration of Musculoskeletal Diseases (2025)
Closed Access
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis
Denis Poddubnyy, Victoria Navarro‐Compán, Murat Torğutalp, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases
Liuting Zeng, Xiang Wang, Wei Xiao, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
State-of-the-Art Review on the Treatment of Axial Spondyloarthritis
Evripidis Kaltsonoudis, Panagiota Karagianni, Tereza Memi, et al.
Medical Sciences (2025) Vol. 13, Iss. 1, pp. 32-32
Open Access
The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study
Jie Chang, Gang Wang
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
Fabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 5, pp. 103533-103533
Open Access | Times Cited: 4
Treatment overview of axial spondyloarthritis in 2023
Xenofon Baraliakos, Uta Kiltz, Irina Kononenko, et al.
Best Practice & Research Clinical Rheumatology (2023) Vol. 37, Iss. 3, pp. 101858-101858
Closed Access | Times Cited: 10
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment
Ilaria Faggiani, Jacopo Fanizza, Ferdinando D’Amico, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1839-1839
Open Access | Times Cited: 3
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis
Dennis McGonagle, Roberta Ramonda, Laura Scagnellato, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 1, pp. 103405-103405
Closed Access | Times Cited: 8
Axial spondyloarthritis guidelines – aiming for maximum impact
Mathieu Choufani, Jonathan Kay, Joerg Ermann
Current Opinion in Rheumatology (2024)
Closed Access | Times Cited: 2
Managing Psoriatic Arthritis Patients Presenting with Axial Symptoms
Denis Poddubnyy
Drugs (2023) Vol. 83, Iss. 6, pp. 497-505
Open Access | Times Cited: 6
Axial Spondyloarthritis: Evolving concepts regarding the disease's diagnosis and treatment
Alexandros A. Drosos, Aliki I. Venetsanopoulou, Paraskevi V. Voulgari
European Journal of Internal Medicine (2023) Vol. 117, pp. 21-27
Closed Access | Times Cited: 6
Exploring the emotional impact of axial Spondyloarthritis: a systematic review and thematic synthesis of qualitative studies and a review of social media
Nicky Wilson, Jia Liu, Qainat Adamjee, et al.
BMC Rheumatology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Greetings from the editor 2023
Josef S Smolen
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 1, pp. 1-2
Open Access | Times Cited: 5
Assessment of clinical and radiological characteristics of Japanese patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
Yu Mori, Takuya Izumiyama, Hiroshi Okuno, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 4, pp. 806-812
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top